| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000042345 |
| Receipt No. | R000048343 |
| Scientific Title | A study of the characteristics of twin gestational diabetes mellitus |
| Date of disclosure of the study information | 2020/11/04 |
| Last modified on | 2020/11/04 (Ver. 1) |
| Basic information | ||
| Public title | A study of the characteristics of twin gestational diabetes mellitus | |
| Acronym | A study of the characteristics of twin gestational diabetes mellitus | |
| Scientific Title | A study of the characteristics of twin gestational diabetes mellitus | |
| Scientific Title:Acronym | A study of the characteristics of twin gestational diabetes mellitus | |
| Region |
|
|
| Condition | ||
| Condition | gestational diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the risk factors for GDM in Japanese twin pregnancies, pregnancy and delivery outcomes, and the clinical course of GDM |
| Basic objectives2 | Others |
| Basic objectives -Others | The purpose of this study was to investigate the course and delivery outcome of gestational diabetes in twin mothers managed at a single perinatal center in Japan, and to compare them with twin mothers diagnosed with non-GDM and single GDM pregnant women at the same time, in order to elucidate the risk factors for GDM, gestational delivery outcome, and clinical course of GDM in twin pregnancies in Japan. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | the risk factors for GDM
pregnancy and delivery outcomes the clinical course of GDM |
| Key secondary outcomes | 1) Patient's basic information: age, BMI, weight, and previous pregnancy
2) Gestational history of pregnancy and delivery: 50 g GCT results, 75 g OGTT results, membranous diagnosis, weight gain, number of days in pregnancy, maternal perinatal complications 3) Clinical information on the child: sex, child weight, neonatal pseudomortality, and Apgar score 4) Placenta findings: placenta weight 5) Treatment: insulin unit count 6) Postpartum information: postpartum 75gOGTT results 7) Patient's medical record information: history of gestational diabetes, history of giant birth, history of congenital anomalies, history of preterm birth, PCOS, family history of diabetes, history of miscarriage (SA), history of abortion (KA), history of infertility treatment, blood pressure, smoking history, history of alcohol consumption. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Patients who gave birth after 22 weeks and 0 days of gestation between January 1, 2011 and December 31, 2016 at the Yokohama City University General Medical Center for Maternal and Child Health, and who were registered in the Maternity Registration Database, who had (1) twin pregnancies or (2) singleton and gestational diabetes mellitus. | |||
| Key exclusion criteria | No selection or exclusion criteria were established for case selection. | |||
| Target sample size | 1194 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yokohama City University Medical Center | ||||||
| Division name | Department of endocrinology & metabolism | ||||||
| Zip code | 232-0024 | ||||||
| Address | 4-57 Urafune-cho, Minami-ku, Kanagawa | ||||||
| TEL | 045-261-5656 | ||||||
| yamakat@yokohama-cu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yokohama City University Medical Center | ||||||
| Division name | Department of endocrinology & metabolism | ||||||
| Zip code | 232-0024 | ||||||
| Address | 4-57 Urafune-cho, Minami-ku, Kanagawa | ||||||
| TEL | 045-261-5656 | ||||||
| Homepage URL | |||||||
| konmai25@gmail.com | |||||||
| Sponsor | |
| Institute | Yokohama City University Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | This research will be funded by the basic research funds of the department to which the principal investigator belongs. |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Yokohama City University Hospital, a public university Center for Advanced Medical Sciences, 5th Floor, P504 Clinical Trial Management Office |
| Address | 3-9 Fukuura, Kanazawa-ku, Yokohama City |
| Tel | 0457872714 |
| chiken@yokohama-cu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 1194 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | This is a retrospective observational study using existing medical record information from routine practice, and no burden or risk is expected to arise from participation in this study. The results of the study may be beneficial for future advances in the treatment of twin gestational diabetes mellitus. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048343 |